DRUG · Mapped RxNorm record
liraglutide
Normalized identity: liraglutide View linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
NCT00318422
Study summary
ClinicalTrials.govEffect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
rosiglitazone
Normalized identity: rosiglitazone View linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
glimepiride
Normalized identity: glimepiride View linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Diabetesverified · MONDO: diabetes mellitus
Interventions
liraglutideDRUG · verified · RxNorm: liraglutide
rosiglitazoneDRUG · verified · RxNorm: rosiglitazone
glimepirideDRUG · verified · RxNorm: glimepiride
Sponsors & collaborators
Novo Nordisk A/Slead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00318422 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.